Home » Authors » David N. Leff

Articles by David N. Leff

From the Lab: Embryonic cells create heart-like muscle cells

Sep. 1, 2001

By David N. Leff

From the Lab: Antistroke compound is proven in animals

Aug. 1, 2001

By David N. Leff

From the Lab: Zebrafish larvae point to curbing cholesterol

July 1, 2001

By David N. Leff

Penn scientists plumb depths of protection against stroke, CVD

April 2, 2001

By David N. Leff

From the Lab: Arteries injured by stents are fixed, in pigs, by gene therapy

Dec. 1, 2000

By David N. Leff

Heparin's oddball molecular structure yields to analytical tool

Nov. 1, 2000

By David N. Leff

Pregnancy-induced hypertension caused by mutant hormone

Aug. 1, 2000

By David N. Leff

Peptide blocking of clotting cascade points to thrombosis therapy

May 1, 2000

By David N. Leff

'Stunned myocardium' syndrome is traced to reaction of protein

March 1, 2000

By David N. Leff

Triple-Threat HIV-Inhibiting Regimen Allows Virus-Battered Immune System To Regenerate

May 10, 1999

By David N. Leff

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...